A Qualitative Comparison of the Abbott SARS-CoV-2 IgG II Quant Assay against Commonly Used Canadian SARS-CoV-2 Enzyme Immunoassays in Blood Donor Retention Specimens, April 2020 to March 2021
ABSTRACT Our group has previously used laboratory and commercially developed assays to understand the IgG responses to SARS-CoV-2 antigens, including nucleocapsid (N), spike (S), and receptor binding domain (RBD), in Canadian blood donors. In this current study, we analyzed 17,428 available and prev...
Main Authors: | Kento T. Abe, Bhavisha Rathod, Karen Colwill, Anne-Claude Gingras, Ashleigh Tuite, Ninette F. Robbins, Guillermo Orjuela, Craig Jenkins, Valerie Conrod, Qi-Long Yi, Sheila F. O’Brien, Steven J. Drews |
---|---|
Format: | Article |
Language: | English |
Published: |
American Society for Microbiology
2022-06-01
|
Series: | Microbiology Spectrum |
Subjects: | |
Online Access: | https://journals.asm.org/doi/10.1128/spectrum.01134-22 |
Similar Items
-
Utilization of the Abbott SARS-CoV-2 IgG II Quant Assay To Identify High-Titer Anti-SARS-CoV-2 Neutralizing Plasma against Wild-Type and Variant SARS-CoV-2 Viruses
by: Yi-Chan J. Lin, et al.
Published: (2022-10-01) -
SARS-CoV-2 Virus-Like Particle Neutralizing Capacity in Blood Donors Depends on Serological Profile and Donor-Declared SARS-CoV-2 Vaccination History
by: Steven J. Drews, et al.
Published: (2022-02-01) -
Estimating SARS-CoV-2 Seroprevalence in Canadian Blood Donors, April 2020 to March 2021: Improving Accuracy with Multiple Assays
by: Ashleigh R. Tuite, et al.
Published: (2022-02-01) -
Diminished Neutralization Capacity of SARS-CoV-2 Omicron BA.1 in Donor Plasma Collected from January to March 2021
by: Yi-Chan J. Lin, et al.
Published: (2023-08-01) -
Performance comparison between Elecsys Anti-SARS-CoV-2 and Anti-SARS-CoV-2 S and Atellica IM SARS-CoV-2 Total and SARS-CoV-2 IgG assays
by: Seri Jeong, et al.
Published: (2022-06-01)